Dr Reddy’s launches India’s first immuno-oncology drug to treat rare form of head and neck cancer

Dr Reddy’s launches India’s first immuno-oncology drug to treat rare form of head and neck cancer

Dr Reddy’s Laboratories on November 28 launched India’s first immuno-oncology drug, Toripalimab, to treat a rare…

Continue Reading
Cancer-associated financial burden in German head and neck cancer patients

Cancer-associated financial burden in German head and neck cancer patients

Introduction Today, we observe enormous progress in cancer treatment with increasingly new options to potentially improve…

Continue Reading
Head and Neck Cancer Drugs Market Size to Hit US$ 2.99 Bn

Head and Neck Cancer Drugs Market Size to Hit US$ 2.99 Bn

Ottawa, Feb. 11, 2022 (GLOBE NEWSWIRE) — The global head and neck cancer drugs market size was…

Continue Reading
Air pollution found to contribute to head and neck cancer incidence

Air pollution found to contribute to head and neck cancer incidence

A recent study published in the journal Scientific Reports correlates higher levels of pollutant particulate matter…

Continue Reading
Tumor-Killing Technology in Head and Neck Cancer

Tumor-Killing Technology in Head and Neck Cancer

The era of treating every patient with head and neck cancer with the same regimen—a combination…

Continue Reading
Drinking tea, coffee linked to lower risk of head and neck cancer: Study

Drinking tea, coffee linked to lower risk of head and neck cancer: Study

Drinking tea or coffee is associated with a lower risk of developing cancers of the head…

Continue Reading